Press Releases April 28, 2026 12:08 PM

Li Bang International Announces Regaining Compliance with Nasdaq Minimum Bid Price Requirement

Li Bang International Regains Nasdaq Compliance by Meeting Minimum Bid Price Requirement

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
LBGJ

Li Bang International Corporation Inc., a Chinese manufacturer of stainless steel commercial kitchen equipment, announced it has regained compliance with Nasdaq's minimum bid price requirement after its stock price remained above $1.00 per share for 20 consecutive business days. This development resolves the previous deficiency notification received in November 2025, ensuring continued listing on the Nasdaq Stock Market.

Li Bang International Announces Regaining Compliance with Nasdaq Minimum Bid Price Requirement
LBGJ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Company designs, produces, and sells stainless steel commercial kitchen equipment under its own brand in China.
  • Nasdaq confirmed the company's stock closing price met the minimum requirement of $1.00 for 20 consecutive business days, restoring compliance.
  • This compliance helps the company maintain its listing on Nasdaq, supporting investor confidence and market presence.

JIANGYIN, China, April 28, 2026 (GLOBE NEWSWIRE) -- Li Bang International Corporation Inc. ("Li Bang International") and its subsidiaries (collectively, the "Company," "we," "us," "our company," or "Li Bang") (Nasdaq: LBGJ), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced that on April 28, 2026, the Company received a formal notification letter from the Nasdaq Listing Qualifications Department confirming that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Stock Market.

Previously on November 7, 2025, Nasdaq notified the Company that its listed securities failed to maintain a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, as required by the Nasdaq Listing Rule 5550(a)(2).

The recent notification from Nasdaq indicated that for the 20 consecutive business days from March 30, 2026, to April 27, 2026, the closing bid price of the Company's Class A Ordinary Shares was at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2), and Nasdaq has stated that this matter is now closed.

About Li Bang International Corporation Inc.

Li Bang International Corporation Inc. specializes in the development, production, and sale of stainless-steel commercial kitchen equipment under its own "Li Bang" brand in China. In addition to its product offerings, the Company provides comprehensive services from early-stage design of commercial kitchen appliances to equipment installation and after-sales maintenance. Committed to innovation and high-quality, the Company uses modern production facilities and mature procedures and strives to become a first-class commercial kitchen appliance manufacturer in China. The Company's long-term vision is to establish itself as a household name, synonymous with the products it manufactures. For more information, please visit the company's website at https://ir.libangco.cn.

Forward Looking Statements

Certain statements in this announcement constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may”, “could”, “will”, “should”, “would”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “project” or “continue” or the negative of these terms or other comparable terminology. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's financial results filings with the U.S. Securities and Exchange Commission.

CONTACTS
Li Bang International Corporation Inc.
Investor Relations Department
Email: [email protected]

WFS Investor Relations
Email: [email protected]
Phone: +1 628 283 9214


Risks

  • Future stock price volatility could lead to another failure to meet Nasdaq's minimum bid price requirement, risking delisting.
  • The company operates in the competitive commercial kitchen equipment sector in China, facing potential market and operational risks.
  • Forward-looking statements disclosed indicate uncertainties related to financial performance, strategy execution, and market conditions impacting results.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026